| Literature DB >> 10540787 |
J G Devlin1, P Garry, D Fitzgerald.
Abstract
Twenty geriatric subjects were treated with recombinant human growth hormone and results compared with a control group. The maximum dose of 3 units per day for 4 months was achieved in all patients. All patients had established atherosclerosis. Doppler Flow Studies were carried out at zero, 6 and 16 weeks. No alteration in plaque size or intima media thickness was observed. An increase in peak velocity in the treated group with a decrease in the control group in the left internal carotid artery only was observed. The study demonstrated a reduction in antero-posterior diameter of the left internal carotid in the treated group but the lesion grading remained unaltered. The expected reduction in total cholesterol LDL was however accompanied by a significant transient increase in triglyceride and P.A.I. 1. Fibrinogen levels were unaltered.Entities:
Mesh:
Substances:
Year: 1999 PMID: 10540787 DOI: 10.1007/bf02945852
Source DB: PubMed Journal: Ir J Med Sci ISSN: 0021-1265 Impact factor: 1.568